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For nearly 8 decades, N. gonorrhoeae has been con-
trollable. Continued investment in research and the de-
velopment of new laboratory technology are critical in 
supporting an effective response to mitigate the threat of 
untreatable gonorrhea.
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To the Editor: As an increasing number of autochtho-
nous Zika virus infections are reported from several South 
America countries (1), we read with interest the report from 
Musso et al. on the potential sexual transmission of Zika 
virus (2). We report additional evidence for this potential 
route of transmission after identification of an imported 
case of infection into the United Kingdom.
After an outbreak alert for Zika in French Polynesia, ac-
tive screening was implemented at Public Health England 
(Porton Down, United Kingdom). In 2014, a 68-year-old 
man had onset of fever, marked lethargy, and an erythema-
tous rash 1 week after returning from the Cook Islands. Se-
rum samples taken 3 days into the febrile illness tested nega-
tive for dengue and chikungunya viruses by real-time reverse 
transcription PCR (rRT-PCR). Test results for dengue virus 
IgM and chikungunya virus IgM also were negative; a test 
result for dengue virus IgG was indeterminate.
An rRT-PCR test result for Zika virus (3) was positive 
and indicated a crossing threshold value of 35 cycles. This 
low viral load, commonly observed even in the acute phase 
of disease (3), meant that attempts to obtain sequence data 
were unsuccessful. Convalescent-phase serum, urine, and 
semen samples were requested; only semen was positive 
for by rRT-PCR, at 27 and 62 days after onset of febrile 
illness. These results demonstrated stronger signals than 
those obtained in tests of the original serum sample, 
with crossing threshold values of 29 and 33 cycles, re-
spectively. Zika virus–specific plaque reduction neutral-
ization test results were positive on convalescent-phase 
serum samples.
Although we did not culture infectious virus from se-
men, our data may indicate prolonged presence of virus in 
semen, which in turn could indicate a prolonged potential 
for sexual transmission of this flavivirus. Moreover, these 
findings could inform decisions regarding what control 
methods are implemented and which specimen types are 
best suited for diagnostic detection.
References
  1. Pan American Health Organization. Reported increase of  
congenital microcephaly and other central nervous system  
symptoms—epidemiological update [cited 2016 Feb 4].  
http://www.paho.org/hq/index.php?option=com_content&view= 
article&id=1239&Itemid=2291&lang=en
  2. Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau 
V-M. Potential sexual transmission of Zika virus. Emerg Infect Dis. 
2015;21:359–61. http://dx.doi.org/10.3201/eid2102.141363
  3. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ,  
Johnson AJ, et al. Genetic and serologic properties of Zika 
virus associated with an epidemic, Yap State, Micronesia, 2007. 
Emerg Infect Dis. 2008;14:1232–9. http://dx.doi.org/10.3201/
eid1408.080287
Address for correspondence: Barry Atkinson, Public Health England, 
Porton Manor Farm Rd, Salisbury SP4 0JG, UK; email:  
barry.atkinson@phe.gov.uk
940 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 22, No. 5, May 2016
LETTERS
